Concepedia

Author

Philippe Rodon

Centre Hospitalier Universitaire de Grenoble

Also Known As

Cyrille Hulin, P Rodon, P. Rodon, Philippe Rodon, Rodon, P., Rodon, Philippe

93

Publications

2.9K

Citations

25

H-Index

38

Concepts

All Affiliations

Centre Hospitalier Universitaire de GrenobleSorbonne UniversitéInstitut Paoli-CalmettesCentre Hospitalier Universitaire de ToursCentre Hospitalier Universitaire de Rennes
PR

About

Philippe Rodon is an author at Centre Hospitalier Universitaire de Grenoble specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

838

2

Health Sciences

7

7

439

3

Immunology

6

6

692

4

Marrow Transplantation

2

2

276

5

Neurology

2

2

102

Philippe Rodon

×

31

Publications

2.5K

Citations

22

H-Index

YearCitations

Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial

Cyrille Hulin, Thierry Façon, Philippe Rodon,

Journal of Clinical Oncology

2009

380

VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial

Philippe Moreau, Cyrille Hulin, Margaret Macro,

Blood

2016

273

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee,

The Lancet Infectious Diseases

2019

242

Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma

Thierry Façon, J. Jenifer Florence Mary, Jean‐Luc Harousseau,

Journal of Clinical Oncology

2006

195

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

Aurore Perrot, Valérie Lauwers‐Cancès, Elodie Tournay,

Journal of Clinical Oncology

2019

175

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

Marie‐Lorraine Chrétien, Jill Corre, Valérie Lauwers‐Cancès,

Blood

2015

114

Chromosomal Abnormalities Are Major Prognostic Factors in Elderly Patients With Multiple Myeloma: The Intergroupe Francophone du Myélome Experience

Hervé Avet‐Loiseau, Cyrille Hulin, L. Campion,

Journal of Clinical Oncology

2013

114

Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results

Xavier Leleu, Lionel Karlin, Margaret Macro,

Blood

2015

100

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Thierry Façon, Christopher P. Venner, Nizar J. Bahlis,

Blood

2021

94

The Clinical Spectrum of IgM-Related Amyloidosis

Benjamin Terrier, Arnaud Jaccard, Jean‐Luc Harousseau,

Medicine

2008

83

Page 1